ChinaBio News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News

ChinaBio will appear in the Feb. issue of Nature Biotechnology.

Click Here to Download

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Phytomedics Testing TCM Drug for Rheumatoid Arthritis

publication date: Sep 18, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Phytomedics of Jamesburg, New Jersey is developing a TCM drug that has begun a Phase III trial in patients with rheumatoid arthritis. PMI-001 is extracted from the skinned root of the Thunder God vine, whose leaves, flowers, and root skin can be poisonous. In China, it is taken for excessive menstrual periods or autoimmune diseases, including rheumatoid arthritis, multiple sclerosis, and lupus. PMI-001 is an oral drug, protected by six patents, that has shown anti-inflammatory and immunosuppressant effects. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events

SEED Finalists Coaching Day
March 2, 2010
Shanghai, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
 
Partner Events

March 8–10, 2010
Barcelona, Spain

World CRO Summit 2010
March 11-12, 2010
Shanghai, China

BIO-Europe 2010
Munich, Germany
November 15–17, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners